The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The impact of body mass index on treatment recommendations for patients with intermediate risk prostate cancer.
Kosj Yamoah
Disclosure not yet available
Alice S. Whittemore
Disclosure not yet available
S. Bruce Malkowicz
Disclosure not yet available
Elaine Spangler
Disclosure not yet available
Michael W. Kattan
Disclosure not yet available
Adam Dicker
Disclosure not yet available
Timothy R. Rebbeck
Disclosure not yet available